BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vila-corcoles A, Hospital I, Ochoa-gondar O, Satue E, de Diego C, Vila-rovira A, Gómez-bertomeu F, Raga X, Aragón M. Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination in middle-aged and older adults: The EPIVAC cohort study, 2015–2016. Vaccine 2020;38:1170-80. [DOI: 10.1016/j.vaccine.2019.11.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Navarro-Torné A, Montuori EA, Kossyvaki V, Méndez C. Burden of pneumococcal disease among adults in Southern Europe (Spain, Portugal, Italy, and Greece): a systematic review and meta-analysis. Hum Vaccin Immunother 2021;17:3670-86. [PMID: 34106040 DOI: 10.1080/21645515.2021.1923348] [Reference Citation Analysis]
2 Hsiao A, Hansen J, Timbol J, Lewis N, Isturiz R, Alexander-Parrish R, McLaughlin JM, Gessner BD, Klein NP. Incidence and Estimated Vaccine Effectiveness Against Hospitalizations for All-Cause Pneumonia Among Older US Adults Who Were Vaccinated and Not Vaccinated With 13-Valent Pneumococcal Conjugate Vaccine. JAMA Netw Open 2022;5:e221111. [PMID: 35302634 DOI: 10.1001/jamanetworkopen.2022.1111] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Fukuda N, Kobayashi N, Masuda M, Wakabayashi A, Kusano N, Watanabe K, Horita N, Hara Y, Nishikawa M, Kaneko T. Clinical Features and Risk Factors for Mortality in Hospitalized Older Adults with Pneumonia. Can Respir J 2021;2021:5644824. [PMID: 34824650 DOI: 10.1155/2021/5644824] [Reference Citation Analysis]
4 Niederman MS, Folaranmi T, Buchwald UK, Musey L, Cripps AW, Johnson KD. Efficacy and effectiveness of a 23-valent polysaccharide vaccine against invasive and noninvasive pneumococcal disease and related outcomes: a review of available evidence. Expert Rev Vaccines 2021;20:243-56. [PMID: 33478306 DOI: 10.1080/14760584.2021.1880328] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Noguchi S, Yatera K, Muramatsu K, Fujino Y, Matsuda S, Mukae H. Mortality changes for patients with pneumococcal pneumonia from 2012 to 2017 in Japan. J Infect Chemother 2022:S1341-321X(22)00181-7. [PMID: 35718263 DOI: 10.1016/j.jiac.2022.06.006] [Reference Citation Analysis]